GSK Plc plans to buy back £2 billion ($2.5 billion) of shares as it raised its long-term growth outlook on optimism around ...

"Among individuals undergoing medication abortion beyond 13 weeks, those with a BMI ≥30 were 6.62 times more likely to ...

Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.

Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...

Here are more doctors and nurses who are willing to share their shocking experiences, sourced from the BuzzFeed Community, ...

U.S. farmers and various trade groups are very apprehensive about not only the potential negative impacts of tariffs on the U ...

Many factors, including breed, size and quality of care ... Begin by evaluating various spending categories such as food, ...

As harsh winter weather swept the nation’s capital, President Donald Trump commenced his second term by signing a blizzard of Executive Orders ...

Today, there is only Call of Duty, but it would be generous to pretend it could have solidified this grip on the scene ...

With over 150+ pages, complete table of contents, 180+ figures, tables, and charts, along with insightful analysis ... This report provides a comprehensive analysis, detailing market size, forecast, ...

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

As Lewis and Clark’s Corps of Discovery made its way across the continent to Oregon, the men (and woman) of the party ...